Description

GLP3-RT | 30mg | Triple Incretin Receptor Research Peptide

Description

GLP3-RT is a synthetic triple-receptor agonist peptide studied in laboratory environments for its activity at the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCGR) receptors. This multi-pathway interaction allows researchers to investigate complex hormonal signaling networks involved in metabolic regulation and endocrine function.

Unlike single or dual incretin receptor agonists, activates three metabolic hormone pathways simultaneously. This characteristic makes the compound a valuable research tool for studying integrated metabolic signaling systems and receptor cross-talk in controlled laboratory models.

Researchers frequently examine in studies focused on hormone signaling pathways, energy balance mechanisms, and receptor-mediated metabolic responses. Its engineered peptide sequence includes stability-enhancing amino acids designed to support peptide durability in laboratory conditions.

This vial contains 50mg of lyophilized GLP3-RT peptide intended strictly for controlled in vitro laboratory research.

Specifications

• Compound: GLP3-RT
• Unit Size: 30mg (lyophilized powder, single vial)
• Molecular Formula: C225H348N48O68
• Molecular Weight: ~4813 g/mol
• CAS Number: 2381089-83-2
• Purity: ≥98%
• Form: Lyophilized peptide powder
• Solubility: Soluble in sterile or bacteriostatic water according to laboratory protocols
• Storage (lyophilized): Store in a cool, dry environment protected from light and moisture
• Storage (reconstituted): Refrigerate between 2–8 °C according to laboratory procedures

Research Applications

Triple Incretin Receptor Signaling Research

GLP3-RT is frequently studied for its ability to activate GLP-1, GIP, and glucagon receptors simultaneously. This property allows researchers to analyze complex interactions between incretin and glucagon signaling pathways in controlled laboratory environments.

Metabolic Pathway Research

Laboratory models utilize to investigate metabolic regulation, endocrine signaling networks, and energy balance mechanisms associated with hormone-mediated metabolic responses.

Hormone Receptor Interaction Studies

The compound is often used in receptor-binding and signal transduction experiments examining how multi-receptor agonists influence downstream cellular pathways compared with single-pathway agonists.

Energy Regulation Research

Researchers may examine GLP3-RT in studies exploring mechanisms involved in energy expenditure, metabolic signaling pathways, and hormone-mediated cellular responses.

Integrated Endocrine System Research

The triple agonist structure of enables researchers to investigate cross-communication between metabolic hormone systems within experimental models

Intended Use

GLP3-RT is intended for in vitro laboratory research use.

Legal Disclaimer

This product has not been evaluated by the U.S. Food and Drug Administration. No claims are made regarding the treatment, diagnosis, cure, or prevention of any disease. All information provided is intended strictly for scientific and educational purposes only.

Terms of Sale

All sales are final